Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on December 04, 2017, 10:38:27 am
-
According to clinicians who care for those taking opioid agonist therapy (OAT) for addiction to drugs such as heroin and prescription painkillers, there are numerous barriers to treating hepatitis C virus (HCV) among this population. The hope is that by identifying and ultimately modifying such barriers, clinicians will be able to help reduce the high burden of hep C among people who inject drugs (PWID).
Researchers from the C-SCOPE study conducted a cross-sectional survey of 203 health care providers practicing at clinics that provide OAT in the United States (82 clinicians), Canada (16), Europe (92) and Australia (13).
Read more...
https://www.hepmag.com/article/addiction-specialists-identify-barriers-treating-hepatitis-c